Michiko Shimokawa
发表
T. Furukawa,
S. Akiyama,
K. Kawahara,
2018,
Pharmacological research.
C. Hayashi,
Y. Mataki,
A. Tanimoto,
2022,
BMC microbiology.
J. Hirabayashi,
Michiko Shimokawa,
H. Tateno,
2012,
Glycoconjugate Journal.
J. Hirabayashi,
Michiko Shimokawa,
H. Tateno,
2016,
Journal of biochemistry.
J. Hirabayashi,
Michiko Shimokawa,
H. Tateno,
2014,
Bioscience, biotechnology, and biochemistry.
K. Fujita,
K. Kitahara,
Michiko Shimokawa,
2014,
Applied and Environmental Microbiology.
K. Fujita,
K. Kitahara,
Michiko Shimokawa,
2015
.
T. Furukawa,
K. Kawahara,
Masatatsu Yamamoto,
2020,
Oncology letters.
T. Furukawa,
K. Arita,
K. Yoshimoto,
2019,
International journal of molecular sciences.
J. Hirabayashi,
Michiko Shimokawa,
H. Tateno,
2012,
Glycoconjugate Journal.
A. Tanimoto,
T. Akahane,
Michiko Shimokawa,
2022,
Scientific Reports.
A. Tanimoto,
K. Yoshimoto,
T. Akahane,
2022,
Scientific Reports.
S. Natsugoe,
S. Ishigami,
T. Furukawa,
2020,
Oncogenesis.
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme
M. Idogawa,
T. Furukawa,
K. Arita,
2019,
British Journal of Cancer.
T. Terada,
K. Shimizu,
K. Fujita,
2020,
The FEBS journal.
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme
M. Idogawa,
T. Furukawa,
K. Arita,
2019,
British Journal of Cancer.
C. Hayashi,
A. Tanimoto,
M. Nomoto,
2022,
BMC Microbiology.